Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88563665 |
Filing Date: 08/02/2019 |
Input Field |
Entered |
SERIAL NUMBER | 88563665 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT17\IMAGEOUT 17\885\636\88563665\xml1\ RFA0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | AXOVANT GENE THERAPIES |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the wording "AXOVANT" in lower case letters, with the "X" and "O" in stylized lettering, above the wording "GENE THERAPIES". |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 382 x 110 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Axovant Sciences GmbH |
*STREET | Viaduktstrasse 8 |
*CITY | Basel |
*COUNTRY | Switzerland |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
4051 |
LEGAL ENTITY INFORMATION | |
TYPE | gesellschaft mit beschränkter haftung (gmbh) |
STATE/COUNTRY WHERE LEGALLY ORGANIZED | Switzerland |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 01565/2019 |
FOREIGN APPLICATION COUNTRY |
Switzerland |
FOREIGN FILING DATE | 02/05/2019 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
733003 |
FOREIGN REGISTRATION COUNTRY |
Switzerland |
FOREIGN REGISTRATION DATE |
07/01/2019 |
FOREIGN REGISTRATION EXPIRATION DATE |
02/05/2029 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf |
CONVERTED PDF FILE(S) (6 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0003.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0004.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0005.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0006.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0007.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0008.JPG | |
STANDARD CHARACTERS OR EQUIVALENT |
NO |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Scientific and technological services and research and design relating thereto; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 01565/2019 |
FOREIGN APPLICATION COUNTRY |
Switzerland |
FOREIGN FILING DATE | 02/05/2019 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
733003 |
FOREIGN REGISTRATION COUNTRY |
Switzerland |
FOREIGN REGISTRATION DATE |
07/01/2019 |
FOREIGN REGISTRATION EXPIRATION DATE |
02/05/2029 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-1-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf |
CONVERTED PDF FILE(S) (6 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0009.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0010.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0011.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0012.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0013.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0014.JPG | |
STANDARD CHARACTERS OR EQUIVALENT |
NO |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 01565/2019 |
FOREIGN APPLICATION COUNTRY |
Switzerland |
FOREIGN FILING DATE | 02/05/2019 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
733003 |
FOREIGN REGISTRATION COUNTRY |
Switzerland |
FOREIGN REGISTRATION DATE |
07/01/2019 |
FOREIGN REGISTRATION EXPIRATION DATE |
02/05/2029 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-2-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf |
CONVERTED PDF FILE(S) (6 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0015.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0016.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0017.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0018.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0019.JPG | |
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0020.JPG | |
STANDARD CHARACTERS OR EQUIVALENT |
NO |
ATTORNEY INFORMATION | |
NAME | Allison Strickland Ricketts |
ATTORNEY DOCKET NUMBER | AXOV 1910273 |
FIRM NAME | Fross Zelnick Lehrman & Zissu, P.C. |
STREET | 151 West 42nd Street, 17th Floor |
CITY | New York |
STATE | New York |
COUNTRY | United States |
ZIP/POSTAL CODE | 10036 |
PHONE | 212-813-5900 |
EMAIL ADDRESS | ricketts-docket@fzlz.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
OTHER APPOINTED ATTORNEY | Joyce M. Ferraro |
CORRESPONDENCE INFORMATION | |
NAME | Allison Strickland Ricketts |
FIRM NAME | Fross Zelnick Lehrman & Zissu, P.C. |
STREET | 151 West 42nd Street, 17th Floor |
CITY | New York |
STATE | New York |
COUNTRY | United States |
ZIP/POSTAL CODE | 10036 |
PHONE | 212-813-5900 |
*EMAIL ADDRESS | ricketts-docket@fzlz.com; ferraro-docket@fzlz.com |
*AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS RF |
NUMBER OF CLASSES | 3 |
APPLICATION FOR REGISTRATION PER CLASS | 275 |
*TOTAL FEE DUE | 825 |
*TOTAL FEE PAID | 825 |
SIGNATURE INFORMATION | |
SIGNATURE | NOT PROVIDED |
SIGNATORY'S NAME | NOT PROVIDED |
SIGNATORY'S POSITION | NOT PROVIDED |
DATE SIGNED | NOT PROVIDED |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88563665 |
Filing Date: 08/02/2019 |
The applicant's current Correspondence Information: |
Allison Strickland Ricketts |
Fross Zelnick Lehrman & Zissu, P.C. |
151 West 42nd Street, 17th Floor |
New York, New York 10036 |
212-813-5900(phone) |
ricketts-docket@fzlz.com;ferraro-docket@fzlz.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services. |
|
|